Stock Comparison
AZN vs LLY
AstraZeneca PLC and Eli Lilly and Company side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$242.97B
$1.04T
P/E (TTM)
23.5
39.1
Forward P/E
15.3
32.1
Price/Sales
4.0
13.0
Price/Book
4.8
30.6
EV/EBITDA
13.2
26.0
Dividend Yield
2.73%
0.53%
Profitability
Net Margin
17.19%
33.53%
Operating Margin
23.69%
43.92%
Return on Equity
22.00%
102.30%
Return on Assets
8.02%
20.40%
Growth (YoY)
Revenue Growth
6.40%
47.70%
Earnings Growth
2.50%
26.20%
Price & Risk
Beta
0.2
0.5
52-Week High
$208.45
$1,235.65
52-Week Low
$144.05
$679.67
Analyst Target
$213.69
$1,297.31
Compare AZN and LLY your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.